Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More General business news Generali shares rise as failed UniCredit proposal puts strategic ownership in focus Generali shares hit a record as UniCredit’s failed Delfin proposal exposes Italy’s fight for influence over the €65bn insurer and its €905bn asset base. bySrinathJune 18, 2026